Nls Pharmaceutics Ag Stock Analysis
| NLSP Stock | USD 1.98 0.02 1.02% |
NLS Pharmaceutics AG is overvalued with Real Value of 1.9 and Hype Value of 1.98. The main objective of NLS Pharmaceutics stock analysis is to determine its intrinsic value, which is an estimate of what NLS Pharmaceutics AG is worth, separate from its market price. There are two main types of NLS Pharmaceutics' stock analysis: fundamental analysis and technical analysis.
The NLS Pharmaceutics stock is traded in the USA on NASDAQ Exchange, with the market opening at 09:30:00 and closing at 16:00:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in the USA. NLS Pharmaceutics is usually not traded on Labour Day, Thanksgiving Day, Christmas Day, New Year 's Day, National Mourning Day, Dr . Martin Luther King Jr 's Birthday, Washington 's Birthday, Good Friday, Memorial Day, Juneteenth Holiday, Independence Day. NLS Stock trading window is adjusted to America/New York timezone.
NLS |
NLS Stock Analysis Notes
About 41.0% of the company outstanding shares are owned by corporate insiders. The company recorded a loss per share of 6.74. NLS Pharmaceutics had not issued any dividends in recent years. The entity had 1:40 split on the 27th of September 2024. NLS Pharmaceutics AG, a biopharmaceutical company, engages in the discovery and development of therapies for patients with rare and complex central nervous system disorders. The company was incorporated in 2015 and is based in Zurich, Switzerland. Nls Pharmaceutics operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 6 people. To find out more about NLS Pharmaceutics AG contact Alexander MBA at 41 44 512 21 50 or learn more at https://nlspharma.com.NLS Pharmaceutics Investment Alerts
| NLS Pharmaceutics generated a negative expected return over the last 90 days | |
| NLS Pharmaceutics has high historical volatility and very poor performance | |
| NLS Pharmaceutics may become a speculative penny stock | |
| NLS Pharmaceutics has a very high chance of going through financial distress in the upcoming years | |
| NLS Pharmaceutics AG currently holds 1.63 M in liabilities. NLS Pharmaceutics has a current ratio of 0.58, indicating that it has a negative working capital and may not be able to pay financial obligations when due. Note, when we think about NLS Pharmaceutics' use of debt, we should always consider it together with its cash and equity. | |
| Net Loss for the year was (12.17 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| NLS Pharmaceutics AG currently holds about 1.35 M in cash with (9.68 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.08. | |
| Roughly 41.0% of the company outstanding shares are owned by corporate insiders |
NLS Pharmaceutics Upcoming and Recent Events
| 3rd of May 2024 Upcoming Quarterly Report | View | |
| 31st of December 2023 Next Fiscal Quarter End | View |
NLS Market Capitalization
The company currently falls under 'Nano-Cap' category with a current market capitalization of 5.78 M.Technical Drivers
As of the 31st of January, NLS Pharmaceutics secures the Mean Deviation of 5.43, risk adjusted performance of (0.07), and Market Risk Adjusted Performance of 3.31. In respect to fundamental indicators, the technical analysis model lets you check practical technical drivers of NLS Pharmaceutics, as well as the relationship between them.NLS Pharmaceutics Price Movement Analysis
The output start index for this execution was twenty-three with a total number of output elements of thirty-eight. The Bollinger Bands is very popular indicator that was developed by John Bollinger. It consist of three lines. NLS Pharmaceutics middle band is a simple moving average of its typical price. The upper and lower bands are (N) standard deviations above and below the middle band. The bands widen and narrow when the volatility of the price is higher or lower, respectively. The upper and lower bands can also be interpreted as price targets for NLS Pharmaceutics. When the price bounces off of the lower band and crosses the middle band, then the upper band becomes the price target.
NLS Pharmaceutics Outstanding Bonds
NLS Pharmaceutics issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. NLS Pharmaceutics uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most NLS bonds can be classified according to their maturity, which is the date when NLS Pharmaceutics AG has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
| Dana 575 percent Corp BondUS235822AB96 | View | |
| HSBC Holdings PLC Corp BondUS404280DR76 | View | |
| MPLX LP 4125 Corp BondUS55336VAK61 | View |
NLS Pharmaceutics Predictive Daily Indicators
NLS Pharmaceutics intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of NLS Pharmaceutics stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.
NLS Pharmaceutics Forecast Models
NLS Pharmaceutics' time-series forecasting models are one of many NLS Pharmaceutics' stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary NLS Pharmaceutics' historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.About NLS Stock Analysis
Stock analysis is the technique used by a trader or investor to examine and evaluate how NLS Pharmaceutics prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling NLS shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as NLS Pharmaceutics. By using and applying NLS Stock analysis, traders can create a robust methodology for identifying NLS entry and exit points for their positions.
NLS Pharmaceutics AG, a biopharmaceutical company, engages in the discovery and development of therapies for patients with rare and complex central nervous system disorders. The company was incorporated in 2015 and is based in Zurich, Switzerland. Nls Pharmaceutics operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 6 people.
Be your own money manager
As an investor, your ultimate goal is to build wealth. Optimizing your investment portfolio is an essential element in this goal. Using our stock analysis tools, you can find out how much better you can do when adding NLS Pharmaceutics to your portfolios without increasing risk or reducing expected return.Did you try this?
Run Sectors Now
SectorsList of equity sectors categorizing publicly traded companies based on their primary business activities |
| All Next | Launch Module |
Additional Tools for NLS Stock Analysis
When running NLS Pharmaceutics' price analysis, check to measure NLS Pharmaceutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy NLS Pharmaceutics is operating at the current time. Most of NLS Pharmaceutics' value examination focuses on studying past and present price action to predict the probability of NLS Pharmaceutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move NLS Pharmaceutics' price. Additionally, you may evaluate how the addition of NLS Pharmaceutics to your portfolios can decrease your overall portfolio volatility.